AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and ...

The Central Bank of Paraguay has won this year’s Central Banking Award for payment and market infrastructure development, ...

High-level results from the CALYPSO Phase III trial showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical ...

LONDON, UK I March 17, 2025 I High-level results from the CALYPSO Phase III trial showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary ...

OKX has temporarily suspended its decentralized exchange (DEX) aggregator to address misuse by the Lazarus Group, a North ...

The Bank of Korea has declined to consider incorporating bitcoin into its foreign exchange reserves, citing the ...

Pavel Durov said on his Telegram channel that he has returned to Dubai from France amidst an ongoing investigation involving ...

FalconX, a digital asset prime broker, executed the first block trade of CME Group's Solana (SOL) futures with StoneX, ...

One year after its inception, BlackRock's BUIDL, a tokenized treasury fund, has attracted over $1 billion, with recent investments ...

Attorney Gregorio Dalbon has requested the Argentine courts to issue an international arrest warrant for $Libra founder ...

High-level results from the CALYPSO Phase III trial showed that eneboparatide, AZP-3601, an investigational parathyroid hormone receptor 1 ...

The European Commission approves AstraZeneca's Imfinzi for treating patients with limited-stage small-cell lung cancer based ...